2024-09-01 - Analysis Report
##  ISRG Stock Analysis

**Company Overview:** Intuitive Surgical, Inc. (ISRG) is a leading manufacturer and provider of robotic-assisted surgical systems. 

**Performance Analysis:**

**1. Return Rate and Deviation:**

* **ISRG Cumulative Return:** 159.33%
* **S&P 500 (VOO) Cumulative Return:** 89.66%
* **Deviation:** ISRG has outperformed the S&P 500 by 69.67%.
* **Relative Deviation:** 96.93%, indicating a high level of outperformance compared to its historical range.

**2. Recent Price Movement:**

* **Closing Price:** $492.63
* **5-day Moving Average:** $484.71
* **20-day Moving Average:** $474.02
* **60-day Moving Average:** $449.66

ISRG has been experiencing a recent upward trend with the price above all moving averages, suggesting potential continued growth. 

**3. Technical Indicators:**

* **RSI (Relative Strength Index):** 75.94
* **PPO (Percentage Price Oscillator):** -0.01
* **Delta_Previous_Relative_Divergence:** 17.1 (-: short-term decline, +: short-term increase)

The RSI indicates the stock is currently in overbought territory. The PPO suggests a slight downtrend. The positive delta in relative divergence indicates a short-term upward price movement.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-19 | 1.48 | 2.01 B$ |
| 2024-04-19 | 1.54 | 1.89 B$ |
| 2023-10-20 | 1.18 | 1.74 B$ |
| 2023-07-24 | 1.2 | 1.76 B$ |
| 2024-07-19 | 1.2 | 1.76 B$ |

* **Recent Earnings:** The most recent earnings report for Q2 2024 showed strong results with EPS of $1.48, beating analyst estimates of $1.40. Revenue also exceeded expectations at $2.01 Billion, reflecting continued growth in the robotic surgery market. 

* **Outlook:** Intuitive Surgical continues to benefit from the increasing adoption of robotic surgery. The company is expected to continue its strong growth trajectory driven by new product launches, expanding markets, and increasing procedure volumes.

**5. Overall Analysis:**

ISRG has consistently outperformed the market, demonstrating strong growth potential. Recent price action indicates a bullish momentum, with the stock trading above all moving averages. However, the RSI suggests an overbought condition, hinting at a potential correction in the near term. Despite this, the strong earnings performance and positive outlook indicate a solid foundation for continued growth in the long term. 

**6. Recommendation:**

Given the strong fundamentals and recent positive momentum, ISRG remains a compelling investment opportunity. However, investors should be aware of the potential for short-term volatility due to the current overbought condition. Long-term investors seeking exposure to the growing robotic surgery market should consider adding ISRG to their portfolios. 
